CNBT
ARMP icon

Cornerstone National Bank & Trust’s Armata Pharmaceuticals ARMP Stock Holding History

Cornerstone National Bank & Trust’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.4K Hold
1,428
– – ﹤0.01% 190
2026
Q1 		$15.1K Hold
1,428
– – 0.01% 162
2025
Q4 		$8.97K Hold
1,428
– – ﹤0.01% 160
2025
Q3 		$4.25K Hold
1,428
– – ﹤0.01% 164
2025
Q2 		$2.71K Hold
1,428
– – ﹤0.01% 165
2025
Q1 		$2.08K Hold
1,428
– – ﹤0.01% 164
2024
Q4 		$2.64K Hold
1,428
– – ﹤0.01% 159
2024
Q3 		$3.38K Buy
+1,428
New +$3.65K ﹤0.01% 157

Other funds holding ARMP

GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Cornerstone National Bank & Trust's ARMP Position: Q2 2026 in Review

Cornerstone National Bank & Trust held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 1,428 shares worth $8.4K. The position accounts for ﹤0.01% of the portfolio, ranked #190.

Cornerstone National Bank & Trust first reported a position in ARMP in Q3 2024 and has held it in 8 quarters since. The position peaked at $15.1K in Q1 2026. 10 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Cornerstone National Bank & Trust held 1,428 shares of Armata Pharmaceuticals worth $8.4K as of Q2 2026.
  • Cornerstone National Bank & Trust left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Cornerstone National Bank & Trust's portfolio in Q2 2026, its #190 holding.
  • Cornerstone National Bank & Trust first reported a position in Armata Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Cornerstone National Bank & Trust's Armata Pharmaceuticals position peaked at $15.1K in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.